AI
AI

Tag: Gilead

Gilead Sciences Resolves Kickback Allegations Related to HIV Drug Prescriptions

Photo credit: www.cnbc.com Gilead Sciences has reached a settlement amounting to $202 million with the U.S. government and several states,...

The Handmaid’s Tale Season 6 Episode 4: Navigating the Divide Between Gilead and Freedom

Photo credit: www.tvfanatic.com Critic's Rating: 3.5 / 5.03.5In the fourth episode of Season 6 of The Handmaid’s Tale, June faces...

Martin Scorsese Set to Adapt Marilynne Robinson’s Novel ‘Home’

Photo credit: www.publishersweekly.com Apple Original Films is set to adapt Marilynne Robinson’s acclaimed Gilead novels, with the renowned Martin Scorsese...

Transcript of Gilead Sciences (GILD) Q4 2024 Earnings Call

Photo credit: www.fool.com Gilead Sciences (GILD 0.69%)Q4 2024 Earnings CallFeb 11, 2025, 4:30 p.m. ET Contents: Prepared Remarks Questions and...

Gilead Sciences and US Government Reach Settlement in HIV Prevention Drug Patent Dispute, Reports Reuters

Photo credit: www.investing.com Gilead Sciences and U.S. Government Reach Settlement Over HIV Drug Patent Battle Gilead Sciences has successfully resolved a...

Gilead and LEO Pharma Collaborate on Inflammatory Disease Programs, Reports Reuters

Photo credit: www.investing.com Gilead Sciences Collaborates with LEO Pharma on Inflammatory Disease Treatments (Reuters) - Gilead Sciences has announced a significant...

Gilead Sciences Commits $20.1 Million to Assembly Biosciences, Reports Investing.com

Photo credit: www.investing.com Gilead Sciences Expands Stake in Assembly Biosciences Gilead Sciences, Inc. has demonstrated its commitment to Assembly Biosciences, Inc....

Gilead Sciences CFO Offloads $23 Million in Shares, According to Investing.com

Photo credit: www.investing.com Gilead Sciences' Recent Stock Transactions and Strategic Developments In the latest updates from Gilead Sciences, CEO Daniel Dickinson...

Gilead Sciences’ Chief Medical Officer Offloads $15 Million in Stock, Reports Investing.com

Photo credit: www.investing.com Gilead Sciences: Stock Movements and Clinical Advancements Recent filings with the Securities and Exchange Commission reveal significant stock...

Gilead and Merck Reveal Phase 2 Results Demonstrating Sustained Viral Suppression in Adults After Switching to Investigational Oral Once-Weekly Combination Therapy of Islatravir and...

Photo credit: www.investing.com “Novel Investigational Combination Regimen is Advancing to Phase 3 and has the Potential to Become the First...

Why Gilead Sciences Stock Outperformed the Market Today

Photo credit: www.fool.com In the realm of drug development, achieving success in large-scale clinical trials is paramount for manufacturers and...

Gilead Claims Drug Counterfeiting Scheme Uncovered at New York City Pharmacies

Photo credit: www.cnbc.com Gilead Sciences has identified a significant counterfeiting operation involving its HIV medications, which were tampered with and...